Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that current hair loss treatments have limitations and suggests researching new treatments targeting different factors of hair loss.

Men have more severe COVID-19 outcomes than women.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

Androgens significantly affect female hair loss, and hormonal treatments may help.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Finasteride potentially treats hair loss by reducing DHT production.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

AR gene not major factor in female hair loss; different from male hair loss.

Apoptosis contributes to hair loss in androgenetic alopecia.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Finasteride doesn't affect erections much, but may decrease libido in men.

No definitive link between finasteride and male breast cancer, but further research is needed.

Longer CAG repeats in gene linked to more severe hair loss in females.

PRGF treatment safely and effectively helps hair loss.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Dutasteride and finasteride have similar risk for osteoporosis and fractures in older men.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

High TNF-α levels may increase hair loss risk after PRP therapy.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Estrogen helps prevent artery plaque by stopping monocyte capture in blood vessels.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.